Cytosorbents (CTSO) Exchange Rate Effect (2013 - 2026)
Cytosorbents (CTSO) reported Exchange Rate Effect of -$228000.0 for Q1 2026, down 914.29% on a YoY basis from $28000.0 in Q1 2025, and down 116.88% quarter-over-quarter from $1.4 million in Q4 2025.
Cytosorbents (CTSO) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Cytosorbents has reported Exchange Rate Effect for 14 years, with the latest figure at -$228000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 914.29% year-over-year to -$228000.0; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (up 2065.53% YoY), and the FY2025 full-year result was $1.5 million, up 1852.94% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$228000.0, down from $1.4 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $1.4 million in Q4 2025, with the low at -$228000.0 in Q1 2026.
- Historically, Exchange Rate Effect has averaged $47900.4 across 5 years, with a median of -$35003.0 in 2023.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect slumped 3150.12% — and 2025, when it jumped 1374.53%.
- Cytosorbents' Exchange Rate Effect stood at $138734.0 in 2022, then plunged by 171.05% to -$98564.0 in 2023, then fell by 7.54% to -$106000.0 in 2024, then jumped by 1374.53% to $1.4 million in 2025, then slumped by 116.88% to -$228000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$228000.0 (Q1 2026), $1.4 million (Q4 2025), and -$146000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -23.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -19.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 24.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 8.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.66 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -2.80 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -37.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -4.40 Mn |
| 10 | Cytosorbents | 28.80 Mn | 24.00 Mn | 6.13 Mn | -228,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -228,000.00 |
| Mar 31, 2026 | -228,000.00 |
| Dec 31, 2025 | 1.35 Mn |
| Dec 31, 2025 | 1.35 Mn |
| Sep 30, 2025 | -146,000.00 |
| Sep 30, 2025 | -146,000.00 |
| Jun 30, 2025 | 257,000.00 |
| Jun 30, 2025 | 257,000.00 |
| Mar 31, 2025 | 28,000.00 |
| Mar 31, 2025 | 28,000.00 |
| Dec 31, 2024 | -106,000.00 |
| Dec 31, 2024 | -106,000.00 |
| Sep 30, 2024 | 85,000.00 |
| Sep 30, 2024 | 85,000.00 |
| Jun 30, 2024 | -69,782.00 |
| Jun 30, 2024 | -69,782.00 |
| Mar 31, 2024 | 5,782.00 |
| Mar 31, 2024 | 5,782.00 |
| Dec 31, 2023 | -98,564.00 |
| Dec 31, 2023 | -98,564.00 |